Abeona Therapeutics Inc vs YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF — how do they compare? Abeona Therapeutics Inc trades at $7.37 (market cap $421.19M), while YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF trades at $39.79. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | QDTY | |
|---|---|---|
Market Cap | $421.19M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $7.45 | $46.71 |
52-Week Low | $4.17 | $36.57 |
Enterprise Value | $276.10M | — |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →QDTY is an actively managed ETF that employs a synthetic covered call strategy on the Nasdaq-100 Index using zero-days-to-expiration (0DTE) options. It aims to generate high weekly income by selling daily call options, providing limited participation in the index's upside while remaining fully exposed to its downside risk.
Read more on QDTY →